OneStart Americas

After last year’s successes in Europe, SR One and the Oxbridge Biotech Roundtable are teaming up again to expand the largest business plan competition of its kind in the world to the Americas.

First prize: $150,000 + free lab space.

Competition timeline

onestart-us-winner

Partners:

Americas-sponsors-4

Calling all bio-entrepreneurs

We are looking for ideas for innovative technologies with the potential to deliver meaningful impact on patients’ lives.

OneStart is open to aspiring life science entrepreneurs aged 35 35 or younger from all continents. Teams based outside of Europe and the Americas are welcome to apply to the Europe competition. The competition will be run in stages and covers four tracks: drug discovery, medical devices, diagnostics and health IT. Entrants can join individually or as a team, and are encouraged to recruit other scientists and even business students.

Teams will be given access to mentors and other resources, and have the opportunity to network with leading pharmaceutical companies, venture capitalists and advisory firms. A judging panel of experts will select the ultimate winner. The prize will be awarded to the most compelling idea with the potential to impact the lives of patients.

About OneStart Americas

  • $150,000 cash prize
  • Free lab space at San Francisco for 12 months, plus membership in Life Sci organizations
  • Business and IP Support

Want to join a team? Need team members? This year’s Co-Founders Hub opens on 1st October 2014.

 

About SR One

SR One is the independent corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care. Since 1985, SR One has invested in more than 140 companies, and its current portfolio includes approximately 30 private and public companies. For more information, visit: www.srone.com

To enquire or for more information, please first register with OBR and then email onestart@oxbridgebiotech.com.

Join OBR to receive OneStart updates

Contribute to the OBR community - subscribe today for free

Copyright © 2014 Oxbridge Roundtable Ltd - All Rights Reserved